Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report

Hdl Handle:
http://hdl.handle.net/10147/620770
Title:
Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report
Authors:
Waterhouse, Deirdre F; Moloney, Geraldine A; Gargoum, Fatma S; Hayden, Peter S; O'Gorman, Tom
Citation:
Cases Journal. 2009 Sep 14;2(1):7456
Issue Date:
14-Sep-2009
URI:
http://dx.doi.org/10.4076/1757-1626-2-7456; http://hdl.handle.net/10147/620770
Abstract:
Abstract Intracranial plasmacytomas are an uncommon presentation of extramedullary relapse of multiple myeloma. The optimal management of extramedullary plasmacytomas remains unclear, with initial reports of bortezomib showing promising clinical results. We describe a case of multiple extracellular, including intracranial, plasmacytoma, with no evidence of marrow involvement, in a patient with relapsed IgA multiple myeloma. To our knowledge, this is the first reported case of a patient with rapid extramedullary relapse of disease despite recent exposure to bortezomib and dexamethasone.
Language:
en
Local subject classification:
MYELOMA

Full metadata record

DC FieldValue Language
dc.contributor.authorWaterhouse, Deirdre Fen
dc.contributor.authorMoloney, Geraldine Aen
dc.contributor.authorGargoum, Fatma Sen
dc.contributor.authorHayden, Peter Sen
dc.contributor.authorO'Gorman, Tomen
dc.date.accessioned2016-09-30T11:16:40Z-
dc.date.available2016-09-30T11:16:40Z-
dc.date.issued2009-09-14-
dc.identifier.citationCases Journal. 2009 Sep 14;2(1):7456en
dc.identifier.urihttp://dx.doi.org/10.4076/1757-1626-2-7456-
dc.identifier.urihttp://hdl.handle.net/10147/620770-
dc.description.abstractAbstract Intracranial plasmacytomas are an uncommon presentation of extramedullary relapse of multiple myeloma. The optimal management of extramedullary plasmacytomas remains unclear, with initial reports of bortezomib showing promising clinical results. We describe a case of multiple extracellular, including intracranial, plasmacytoma, with no evidence of marrow involvement, in a patient with relapsed IgA multiple myeloma. To our knowledge, this is the first reported case of a patient with rapid extramedullary relapse of disease despite recent exposure to bortezomib and dexamethasone.en
dc.language.isoenen
dc.subject.otherMYELOMAen
dc.titleExtramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case reporten
dc.language.rfc3066enen
dc.rights.holderlicensee BioMed Central Ltd.en
dc.date.updated2016-04-15T16:03:59Zen
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.